PASMI’s position regarding nonsteroidal anti-inflammatory drugs used in infections caused by the SARS-CoV-2019 virus (COVID-19)

18 March 2020 In connection with recent press reports regarding doubts on taking  medicinal substance ibuprofen belonging to the group of non-steroidal anti-inflammatory drugs (NSAIDs), and its impact on the worsening COVID-19 symptoms , PASMI, Polish Association of Self-Medication Industry, based on the European Medicines Agency (EMA) position published today and information from the President of the Office...

PASMI’ s position regarding the Ministry of Health proposal of a tax on food supplement advertising

17 January 2020 On December 20, 2019, on the website of the Government Legislation Center, a draft act was published amending certain acts in order to promote healthy consumer choices, the aim of which is to introduce fiscal policy as a tool to promote healthy nutritional choices in the field of products for which the negative health effects...

PASMI’s position regarding the self-regulation of television broadcasters regarding the dissemination principles of food supplement advertising

25 December 2019 On November 25, 2019 at the headquarters of the The National Broadcasting Council Office, the self-regulation was signed, which was jointly prepared by television broadcasters running advertising activities for their own and represented channels (Polsat Television, Polish Television, TVN Television) and organizations that associate producers of food supplements (PASMI Polish Association of Self Medication Industry”,...

PASMI’s position on position regarding the availability of medications for cold and cough with psychoactive substances to patients

29 March 2019 Warsaw, 29th March 2019 In connection with parliamentary interpellations regarding overuse of non-prescription drugs containing psychoactive substances, such as pseudoephedrine, dextromethorphan and codeine, PASMI, the Polish Association of the Self-Medication Industry, believes that currently applicable regulations are sufficient and that changes in prescription availability status will result in additional load on primary care physicians and,...

PASMI’s position on pain treatment in Poland

15 June 2018 PASMI “Polish Association of Self-Medication Industry” Employers’ Association (further on: “PASMI”) supports the new regulations included in the draft regulation of the Minister of Health of 11th May 2018, indicating that the Regulation will guarantee effective implementation of the patient’s right to pain treatment in accordance with current medical knowledge. The right to treatment is...

PASMI’s position regarding the total ban on the advertisement of over-the-counter drugs

19 February 2018 Warsaw, dated 19th February 2018 PASMI’s position regarding the total ban on the advertisement of over-the-counter drugs, medical devices and food supplements specified in the petition to the Minister of Health published on January 30, 2018   On behalf of PASMI, we would like to point out that the petitioner justifies their demands with the...